Primary amyloidosis

Injury	Disease	Nutrition	Poison

Symptoms	Surgery	Test	Special Topic

Amyloidosis on the fingers

Amyloidosis on the face

Overview

Symptoms

Treatment

Prevention

Primary amyloidosis

Alternative Names:

Amyloid - primary

Treatment:

Some patients with primary amyloidosis respond to chemotherapy directed at the abnormal plasma cells. Autologous stem cell transplanation may be used, as in multiple myeloma.

In secondary amyloidosis, aggressive treatment of the underlying disease can improve symptoms and/or slow progression of disease. Complications such as heart failure, kidney failure, and other problems can sometimes be treated as necessary.

Expectations (prognosis):

The severity of the disease depends upon the organs affected. Heart and kidney involvement may lead to organ failure and death. Systemic involvement is associated with death within 1 to 3 years.

Complications:

heart failure
kidney failure
endocrine failure (hormonal disorder)
respiratory failure
death

Calling your health care provider:

Call your health care provider if symptoms consistent with primary amyloidosis develop.

If you know you have primary amyloidosis, call your health care provider if difficulty breathing, persistent swelling of the ankles or other areas, decreased urine output, or other symptoms occur. This may indicate that complications have developed.

Review Date: 4/15/2005
Reviewed By: Rita Nanda, MD, Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL. Review provided by VeriMed Healthcare Network.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2004 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.